#
##
##
|Trustees'
annual
report|
|---|
|Independent
examiner's
report to the trustees|
|Statement offinancial activities|
|Balance sheet|
|Notes to the financial statements|
##
##
##
##
##
|The trustees|||||
|---|---|---|---|---|
|The trustees|who served during the year and at the date ofapproval|||were as follows:|
|||BSommerlad
(Chairman)|||
|||RAllan|||
|||EAnderson|||
|||J Baldwin (Resigned 19/07/2023)|||
|||M Dwyer|||
|||M Fell|||
|||TGoodacre|||
|||M Gwyther
(Appointed
22/OS/2022)|||
|||N Hay|||
|||YKahn-Pascual|||
|||K Knowles|||
|||T Morris|||
|||M Pinkstone|||
|||BRichard|||
|||D Sainsbury|||
|||R Slator|||
|||R Walker (Resigned
14/OS/2023)|||
|Executive Officer||M Baldwin|||
|Independent|examiner|LThurston
FCCA|||
|||Lovewell Blake LLP|||
|||Chartered
accountants|||
|||First Floor Suite|||
|||2 Hillside Business Park|||
|||Bury St Edmunds|||
|||IP32 7EA|||
|Bankers||Bardays Bank PLC|||
|||North Herts and Welwyn|Group||
|||Hitchin|||
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
CLEFT
Trustees, annual reportfew*
Year ended 30 Juno 2023
3UPPOrt *tiich wnjld teal to wa*ty researth in deft bp pal*. This sit4ed area w&1 nue to
be exFlor&J In ts corytsng year.
of ¢Séft data, namèty The Cleft CoilecaNo and CRANE IrAèase stt and*% bèlow). trj oppcfflunrties
each year for a Trsearo*er to use the d*a atreaty coEteded. Exaclly Ihi$ IKW mLth it
nrright cost would need d•veloprwJ.
CLEFT Away Lkny DIsCu•(¥b and for 21r23rL4
At the CLEFT Awayday tn May 2023, th• Rose*1 StowiyJ lY4)oa that over th• folkn*?ng
frrmn Jldy 1st. 2023. wth a ¢ktsry (J* of 3th. 2023. Al10n5 rrray be m•Je fundiThJ of
irldividual FYoieca5 UP to £50.¢JOO.
. CRANE (Tho Qeft Registy and Audit Netsth} wa5 esta.5 in 2(NXI a5 a rotional deft audit database.
partiripate in the study <>¥*r a kw pwKJd Lrf trrne. ar? ¥ep4fats cohorts: a Birth Coh(¥t aTrJ
a &yèar-(rfd Cohort and can a150 be re¢y¥knl arf•.The aim the St is to
12-
##
##
##
##
##
##
##
|Members ofthe Research|Steering Committee:|||||
|---|---|---|---|---|---|
|Name|Position|||||
|Rona Slator|Chair ofthe Research Steering Committee|||||
|Emity Anderson|Clinical Geneticist, Vice-Chair ofthe Research Steering Committee|||||
|Norman
Hay|Consultant
Orthodontist,
Great Ormond Street Hospital|||||
|Paul Morris|Consultant
Plastic Surgeon, Great Ormond Street Hospital|||||
|Dr Malcolm Birch|Director ofClinical Physics at Barts and the London|||NHS|Trust|
|Prof Phil Stanier|Professor ofCraniofacial
Biology and|Genetics,|University||College London|
|Raouf Chorbachi|Audiological
Physician, Great Ormond|Street Hospital||||
|Fiona Gilchrist|Senior
I ecturer 8 Hon. Consultant
in|Paed. Dentistry||||
|Stephanie
van Eeden|Lead Specialist Speech and Language
Therapist|||||
|JoShearer|Clinical Psychologist|||||
|Yvonne Wren|Chief Investigator
ofthe Cleft Collective|||||
|Helen Robson|Lead Nurse Cleft Lip and Palate|||||
|Sophie Butterworth|Plastic Surgical Trainee|||||
|Ambika Chadha|Oral and maxillo-facial
surgeon|||||
|Prof Martyn Colboume|Professor ofAcademic Orthodontics,|King's College||I ondon||
|Gillian McCarthy|External Engagement
Oflicer, CLAPA|||||
|Resigned from Research Steering Committee||||||
|Name|Position|||||
|Cherry Le Roy|CLAPA Representative
(Resigned October 2022)|||||
|JoShearer|Clinical Psychologist
(Resigned January 2023)|||||
|Nonwotlng
Members ofResearch Steering Committee||||||
|Name|Position|||||
|Mark Dwyer|CLEFTTrustee|||||
|Brian Somrnerlad|Consultant
Plastic Surgeon and Chair|ofthe International|||Committee|
||and ofCLEFT|||||
##
##
##
##
##
##
##
##
##
##
##
##
##
##
||||||||Period from|
|---|---|---|---|---|---|---|---|
||||||||25 May 21 to|
|||||Year|to 30Jun 23||30Jun 22|
|||||Unrestricted|Restricted|||
||||Note|funds
f|funds|Total funds
f|Total funds|
|income and endowments||||||||
|Donations
and legacies
Other trading
activities||||81,242
1,253|150,000
115,260|231,242
116,513|410,892|
|Investment
income||||1,148||1,148||
|Other income||||175||1?5|2,917|
|Total income||||83,818|265,260|349,078|413,809|
|Expenditure||||||||
|Raising funds||||||||
|Costs of raising donations||and||||||
|legacies
Charitable
activities|||8
9|25,758
115,495|26,284|25,758
141,779|30,957
61,495|
|Total expenditure||||141,253|26,284|167,537|92,452|
|Net income and net movement||in funds||(57,435)|238,976|181,541|321,357|
|Reconciliation
offunds||||||||
|Total funds brought|fonivard|||305,257|16,100|321,357||
|Total funds carried|forward|||247,822|255,076|502,898|321,357|
##
##
##
|CLEFT
Balance sheet
30June 2023|||||||
|---|---|---|---|---|---|---|
||||2023||||
|Fixed assets|||||||
|Tangible fixed assets||13||1,161|||
|Current assets|||||||
|Debtors||14|1,198||4,186||
|Gash at bank and in|hand||503,780||318,731||
||||||322,917||
|Cnrdttorsi
Amounts|falling due within||||||
|olla year|||(3,241)||(1,560)||
|Net curnrnt assets||||501,737||321,357|
|Total assets less current liabilities||||502,898||321,357|
|Net assets||||502,898||321,357|
|Funds ofthe charity|||||||
|Restricted funds||||255,076||16,100|
|Unrestricted
funds||||247,822||305,257|
|Total charity funds||16||502,898||321,357|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|Donations|and|legacies (conririued)||||
|---|---|---|---|---|---|
||||Unrestricted|Restricted|Total Funds|
||||Funds|Funds|2022|
||||f|f.||
|Donations||||||
|Donations|||165,037||165,037|
|Donation|upon|incorporation|229,755|16,100|245,855|
||||394,792|16,100|410,892|
##
|||Unrestricted|Restricted|Total Funds|
|---|---|---|---|---|
|||Funds|Funds|2023|
||||f.|f.|
|Fundraising|events|1,253|115,260|116,513|
|||Unrestricted|Restricted|Total Funds|
|||Funds
K|Funds
f|2022
f|
|Fundraising|events||||
##
|||Unrestricted|Total|Funds|Unrestricted|Total|Funds|
|---|---|---|---|---|---|---|---|
|||Funds||2023
f.|Funds
f||2022|
|interest|income|1,148||1,148||||
|Other incom|e|||||||
|---|---|---|---|---|---|---|---|
|||||Unrestricted|Total Funds|Unrestricted|Total Funds|
|||||Funds|2023|Funds|2022|
||||||K||f|
|Royalties received||||||2,917|2,917|
|Compensation||received||175|175|||
|||||175|175|2,917|2,917|
|Costs ofraising donations|||and legacies|||||
|||||Unrestricted|TotalFunds|Unrestricted|Total Funds|
|||||Funds
f|2023
f|Funds
f|2022
f|
|Event costs||||14,078|14,078|30,957|30,957|
|Fundraising|costs|||11,680|11,680|||
|||||25,758|25,758|30,957|30,957|
##
##
##
##
##
|9.|Expenditure
on charitable|activities||||
|---|---|---|---|---|---|
||||Unrestricted|Restricted|Total Funds|
||||Funds|Funds|2023|
||||E||E|
||Research grants
Overseas projects
Support costs||27,949
16,644
70,902|26,284|27,949
42,928
70,902|
||||115,495|26,284|141,779|
||||Unrestricted|Restricted|Total Funds|
||||Funds|Funds|2022|
||||E|E|E|
||Research grants
Overseas projects
Support costs||752
15,975
44,768||752
15,975
44,768|
||||61,495||61,495|
||Analysis ofsupport costs|||||
|||||2023|2022|
|||||E||
||Salaries
Pension costs
Bankcharges
Just giving charges
National
travel|||38,834
535
298
404|20,640
764
146
144|
||international
travel
Membership
fees
IT and website fees
Printing,
postage and stationery
Advertising
and promotions
Consultancy
and specialist staff support
Depreciation
Insurance|||6,252
614
9,535
2,341
692
5,671
51
1,659|50
7,452
1,564
3,907
7,381|
||Independent
examination
fees
Legal and professional
fees|||2,100
1,916|1,560
1,160|
|||||70,902|44,768|
|10.|Net income|||||
||Net income is stated after|charging/(crediting):||2023|2022|
|||||f|E|
||Depreciation
oftangible fixed assets
Fees payable for the audit ofthe financial statements|||51
2,100|1,560|
##
##
##
##
|||2023|2022|
|---|---|---|---|
|||K|F|
|Wages
Pension|and salaries
costs|38,834
535|20,640
764|
|||39,369|21,404|
##
##
##
|13.|Two trustees
received
reimbursed
expenditure
to
year.
Tangible fixed assets|talling
E2,476 (2022: one trustee f14|9) during
the|
|---|---|---|---|
||||Equipment|
||||E|
||Cost|||
||At 1 July 2022
Additions||1,212|
||At 30June 2023||1,212|
||Depreciation|||
||At 1 July 2022|||
||Charge for the year|||
||At 30June 2023||51|
||Carrying
amount
At 30June 2023||1,161|
||At 30June 2022|||
|14.|Debtors|||
|||2023|2022|
||Other debtors|1,198|4,186|
##
##
##
##
##
|||||||2023|2022|
|---|---|---|---|---|---|---|---|
|Trade creditors||||||96||
|Accruals and deferred|income|||||2,100|1,560|
|Social security and other||taxes||||1,045||
|||||||3,241|1,560|
|Analysis ofcharitable|funds|||||||
|Year ended 30June 2023||||||||
||||||||At 30Jun|
||||At 1 Apr 2022
F|Income
F|Expenditure
f|Transfers|2023|
|Restricted Funds||||||||
|Palate Musde Anatomy
Thames)||(Nth|16,100||||16,100|
|Bangladesh - Private Donor
Project||||115,260|(12,165)||103,095|
|Kurdistan - Private Donor||||||||
|Project||||150,000|(14,119)||135,881|
||||16,100|265,260|(26,284)||255,076|
|Designated
funds||||||||
|Vomerine Flap Closure|||20,000||||20,000|
|The impact ofCOVID on
Speech|||20,575||(3,008)||17,567|
|Speech therapy for cleft||||||||
|speech characteristics
Alveolar Bone Graft|project||16,500
3,498||(16,500)||3,498|
|North Thames CLEFT|Q Data|||||||
|(Nth Thames)|||1,215||||1,215|
|Bangladesh
multi-disciplinary
deft centre|||28,000||(22,598)||5,402|
|Orticochea
Pharyngoplasty
(Nth Thames)|||27,186||||27,186|
|Eye Tracking to measure
success in surgery|||14,984||||14,984|
|Kurdistan
project
Mozambique
project||||935
816|(935)
(816)|||
|Nepal project||||1,988|(1,988)|||
|Development
ofAuto Scoring||||||||
|Tool||||49,882|(24,941)||24,941|
||||131,958|53,621|(70,786)||114,793|
|Unrestricted
funds||||||||
|General funds|||173,299|30,917|(70,467)||133,029|
##
##
##
##
|s to the financial stateme
ended 30June 2023|s to the financial stateme
ended 30June 2023|s to the financial stateme
ended 30June 2023|nts
(continued)|||||
|---|---|---|---|---|---|---|---|
|Year ended 30June 2022||||||||
||||At 25 May||||At 30Jun|
||||2021|Income|Expenditure
f|Transfers
F|2022
E|
|Restricted Funds||||||||
|Palate Musde Anatomy||(Nth||||||
|Thames)||||16,100|||16,100|
|Designated
funds||||||||
|UCLP Speech Outcomes||||1,533||(1,533)||
|Vomerine Flap Closure||||22,000||(2,000)|20,000|
|Private Donor||||15,000||(15,000)||
|TBX22Mouse Model Project||||633||(633)||
|Investigation
ofabsent|uvula|||7,759||(7,759)||
|The impact ofCOVID on||||||||
|Speech||||20,575|||20,575|
|Speech therapy for cleft
speech characteristics
project||||16,500|||16,500|
|Alveolar Bone Graft||||3,498|||3,498|
|Submucous
deft palate|repair|||36,650||(36,650)||
|North Thames CLEFT|Q|Data||||||
|(Nth Thames)||||1,215|||1,215|
|Complex craniofacial defts in||||||||
|Bangladesh||||3,821||(3,821)||
|Bangladesh
multi-disciplinary||||||||
|deft centre||||28,000|||28,000|
|Orticochea Pharyngoplasty||||||||
|(Nth Thames)||||27,186|||27,186|
|Eye Tracking to measure
success in surgery||||14,984|||14,984|
|||||||(67,396)|131,958|
|Unrestricted
funds||||||||
|General funds||||198,355|(92,452)|67,396|173,299|
|Purpose ofRestricted|Funds|||||||
##
##
##
##
##
##
|||General|Designated|Restricted|Total|
|---|---|---|---|---|---|
|||Funds|Funds|Funds|Funds|
|30June|2023|||||
|Tangible|fixed assets|1,162|||1,162|
|Current|assets|135,108|114,793|255,076|504,977|
|Current|liabilities|(3,241)|||(3,241)|
|Net Assets||133,029|114,793|255,076|502,898|
|||General|Designated|Restricted|Total|
|||Funds|Funds|Funds|Funds|
|30June|2022|||||
|Current|assets|174,859|131,958|16,100|322,917|
|Current|liabilities|(1,560)|||(1,560)|
|Net Assets||1?3,29S|131,958|16,100|321,357|
##
##
|The total f|uture minimum
lease payments
under non-cancella|ble
operating leases are as foll|ows:|
|---|---|---|---|
|||2023|2022|
|Due within
sefvlclng|1 year: Website lease and|1,868|1,868|
##